Who Holds Adicet Bio, Inc. (ACET)? 56 Institutional Holders, Q2 2026
Managers with more than $100 million in US equities report their holdings on Form 13F within 45 days of each quarter end. Quarter ended 30 Jun 2026: 56 holders, $52 million in total.
Largest holders
The 56 largest by value. Change in shares against Q1 2026.
| Manager | Shares | Value | Change | |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 932,624 | $8 million | -21% | 13F |
| ORBIMED ADVISORS LLC | 844,787 | $7 million | -18% | 13F |
| FRANKLIN RESOURCES INC | 626,571 | $5 million | +0% | 13F |
| CITADEL ADVISORS LLC | 432,738 | $4 million | +13% | 13F |
| VANGUARD CAPITAL MANAGEMENT LLC | 343,228 | $3 million | +2% | 13F |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 274,375 | $2 million | +0% | 13F |
| RENAISSANCE TECHNOLOGIES LLC | 265,945 | $2 million | +14% | 13F |
| Stonepine Capital Management, LLC | 245,518 | $2 million | +11% | 13F |
| Alyeska Investment Group, L.P. | 203,799 | $2 million | +0% | 13F |
| Schonfeld Strategic Advisors LLC | 195,514 | $2 million | New | 13F |
| Carlyle Group Inc. | 184,295 | $2 million | +0% | 13F |
| NEXTBio Capital Management LP | 157,827 | $1 million | +0% | 13F |
| TWO SIGMA INVESTMENTS, LP | 96,839 | $836,689 | +125% | 13F |
| GEODE CAPITAL MANAGEMENT, LLC | 95,634 | $826,703 | -5% | 13F |
| DAFNA Capital Management LLC | 93,812 | $810,536 | +0% | 13F |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 85,959 | $742,686 | New | 13F |
| MARSHALL WACE, LLP | 79,488 | $686,775 | New | 13F |
| Trexquant Investment LP | 78,002 | $673,937 | +79% | 13F |
| JANE STREET GROUP, LLC | 70,561 | $609,647 | +90% | 13F |
| Burkehill Global Management, LP | 62,500 | $540,000 | +0% | 13F |
| BlackRock, Inc. | 62,126 | $536,769 | +70% | 13F |
| REGENERON PHARMACEUTICALS, INC. | 60,511 | $522,819 | New | 13F |
| Rangeley Capital, LLC | 50,892 | $439,707 | -9% | 13F |
| VANGUARD FIDUCIARY TRUST CO | 50,670 | $437,789 | +1% | 13F |
| RBF Capital, LLC | 38,582 | $333,348 | +0% | 13F |
| STATE STREET CORP | 36,222 | $312,958 | +0% | 13F |
| Quadrature Capital Ltd | 36,193 | $312,708 | New | 13F |
| DIMENSIONAL FUND ADVISORS LP | 31,603 | $273,049 | +193% | 13F |
| UBS Group AG | 29,817 | $257,619 | -22% | 13F |
| Verdad Advisers, LP | 25,200 | $217,728 | New | 13F |
| XTX Topco Ltd | 24,284 | $209,814 | +27% | 13F |
| JOHNSON & JOHNSON | 22,779 | $196,811 | +0% | 13F |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 20,650 | $178,416 | New | 13F |
| PRELUDE CAPITAL MANAGEMENT, LLC | 18,550 | $160,272 | New | 13F |
| NORTHERN TRUST CORP | 18,436 | $159,287 | -4% | 13F |
| OCCUDO QUANTITATIVE STRATEGIES LP | 16,636 | $143,735 | +10% | 13F |
| Squarepoint Ops LLC | 15,254 | $131,795 | New | 13F |
| Vontobel Holding Ltd. | 13,776 | $119,025 | -3% | 13F |
| AXQ CAPITAL, LP | 10,991 | $94,962 | New | 13F |
| Jump Financial, LLC | 10,942 | $94,539 | New | 13F |
| Arax Advisory Partners | 6,000 | $51,840 | New | 13F |
| Vanguard Global Advisers, LLC | 5,221 | $45,109 | +0% | 13F |
| SIMPLEX TRADING, LLC | 4,814 | $41,592 | +246% | 13F |
| MORGAN STANLEY | 2,291 | $19,795 | -34% | 13F |
| ROYAL BANK OF CANADA | 1,701 | $15,000 | +0% | 13F |
| Tower Research Capital LLC (TRC) | 277 | $2,393 | -81% | 13F |
| JPMORGAN CHASE & CO | 196 | $1,677 | +2350% | 13F |
| ACADIAN ASSET MANAGEMENT LLC | 124,832 | $1,076 | +6% | 13F |
| BNP PARIBAS FINANCIAL MARKETS | 50 | $432 | +0% | 13F |
| Caitong International Asset Management Co., Ltd | 47 | $406 | +1467% | 13F |
| SBI Securities Co., Ltd. | 24 | $207 | +26% | 13F |
| NATIONAL BANK OF CANADA /FI/ | 17 | $146 | +0% | 13F |
| FMR LLC | 6 | $52 | New | 13F |
| TD Waterhouse Canada Inc. | 3 | $26 | New | 13F |
| DANSKE BANK A/S | 1 | $9 | +0% | 13F |
| Avion Wealth | 246 | $2 | +0% | 13F |
Questions and answers
- How many institutions hold Adicet Bio, Inc.?
- 56 managers reported Adicet Bio, Inc. on Form 13F for the quarter ended 30 June 2026, against 48 the quarter before.
- Who is the largest institutional holder of Adicet Bio, Inc.?
- RA CAPITAL MANAGEMENT, L.P., with 932,624 shares worth $8 million on its 13F for Q2 2026.
- How many institutions bought or sold out of Adicet Bio, Inc. in Q2 2026?
- 14 managers reported a new position and 6 reported none after holding it the quarter before.
Source: SEC EDGAR, Form 13F (public domain). Counts and values as filed. Cite this page: Tamarly Intelligence, "Who holds Adicet Bio, Inc., Q2 2026", https://app.tamarly.ai/holders/adicet-bio, built from SEC EDGAR.
Research from public records, not investment advice. Tamarly holds no investment positions. By reading these pages you accept the Terms of Use; figures can be late or wrong, so check the linked source before relying on one. Terms and policies.